Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 16.09
-0.18 (-1.11%)
Jan 20, 2026, 3:00 PM CST
Shinva Medical Instrument Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 508.92 | 691.61 | 654 | 500.07 | 556.49 | 234.14 | Upgrade |
Depreciation & Amortization | 203.17 | 203.17 | 213.16 | 197.34 | 200.91 | 178.6 | Upgrade |
Other Amortization | 49.62 | 49.62 | 45.12 | 43.78 | 52.84 | 16.08 | Upgrade |
Loss (Gain) From Sale of Assets | -0.6 | -0.6 | -3.75 | -2.51 | -3.53 | 0.46 | Upgrade |
Asset Writedown & Restructuring Costs | 17.33 | 17.33 | 12.87 | 2.03 | 4.51 | 24.97 | Upgrade |
Loss (Gain) From Sale of Investments | -70.82 | -70.82 | -93.65 | 7.48 | -172.94 | -51.12 | Upgrade |
Provision & Write-off of Bad Debts | 120.59 | 120.59 | 116.98 | 64.33 | 35.09 | 82.15 | Upgrade |
Other Operating Activities | 498.3 | 59.78 | 67.35 | 84.52 | 103.56 | -272.9 | Upgrade |
Change in Accounts Receivable | -615.58 | -615.58 | 6.82 | -329.1 | -145.01 | 2.32 | Upgrade |
Change in Inventory | 190.85 | 190.85 | -540.03 | -726.54 | 18.01 | 256.46 | Upgrade |
Change in Accounts Payable | -187.55 | -187.55 | 563.58 | 600.94 | 703.35 | 670.27 | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | - | 2.1 | Upgrade |
Operating Cash Flow | 706.56 | 450.73 | 1,030 | 388.05 | 1,403 | 1,098 | Upgrade |
Operating Cash Flow Growth | 0.08% | -56.24% | 165.46% | -72.33% | 27.72% | 74.05% | Upgrade |
Capital Expenditures | -444.48 | -420.88 | -535.77 | -247.58 | -274.36 | -191.33 | Upgrade |
Sale of Property, Plant & Equipment | 1.16 | 0.24 | 2.59 | 0.82 | 18.69 | 9.61 | Upgrade |
Cash Acquisitions | - | - | - | 0.67 | - | - | Upgrade |
Divestitures | 99.87 | - | 1.24 | - | 162.48 | 33.97 | Upgrade |
Investment in Securities | 35.01 | 43.31 | -4.67 | -40.5 | 205.09 | 11.7 | Upgrade |
Other Investing Activities | 51.04 | 58.64 | 16.71 | 5.36 | 10.31 | 2.85 | Upgrade |
Investing Cash Flow | -257.4 | -318.71 | -519.9 | -281.22 | 163.89 | -28.39 | Upgrade |
Long-Term Debt Issued | - | 1,024 | 1,153 | 1,321 | 1,071 | 2,199 | Upgrade |
Long-Term Debt Repaid | - | -1,081 | -1,232 | -1,214 | -2,346 | -2,876 | Upgrade |
Net Debt Issued (Repaid) | -73.97 | -56.14 | -78.69 | 106.99 | -1,275 | -676.45 | Upgrade |
Issuance of Common Stock | - | - | 1,276 | 62.46 | - | 0.39 | Upgrade |
Common Dividends Paid | -198.97 | -329.03 | -103.8 | -96.95 | -128.68 | -183.28 | Upgrade |
Other Financing Activities | 88.92 | -21.96 | -27.95 | -44.68 | -4.12 | - | Upgrade |
Financing Cash Flow | -184.21 | -407.13 | 1,066 | 27.81 | -1,407 | -859.34 | Upgrade |
Foreign Exchange Rate Adjustments | 3.97 | 4.03 | 6.95 | 1.4 | 0.24 | 0.01 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.01 | Upgrade |
Net Cash Flow | 268.91 | -271.07 | 1,583 | 136.04 | 159.31 | 210.37 | Upgrade |
Free Cash Flow | 262.07 | 29.85 | 494.34 | 140.47 | 1,128 | 906.78 | Upgrade |
Free Cash Flow Growth | -20.34% | -93.96% | 251.91% | -87.55% | 24.42% | 118.43% | Upgrade |
Free Cash Flow Margin | 2.74% | 0.30% | 4.94% | 1.51% | 11.90% | 9.91% | Upgrade |
Free Cash Flow Per Share | 0.40 | 0.05 | 0.82 | 0.27 | 2.14 | 1.73 | Upgrade |
Cash Income Tax Paid | 391.4 | 434.79 | 419.57 | 486.1 | 546.32 | 405 | Upgrade |
Levered Free Cash Flow | 116.87 | -359.7 | 311.47 | 115.25 | 948.4 | 994.11 | Upgrade |
Unlevered Free Cash Flow | 143.59 | -331.71 | 340.89 | 150.83 | 996.06 | 1,070 | Upgrade |
Change in Working Capital | -619.94 | -619.94 | 18.05 | -508.67 | 625.29 | 885.73 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.